mFOLFOXIRI plus Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer m(CRC): an update of the randomized phase II VOLFI trial of the AIO (AIO-KRK0109)
ONCOLOGY RESEARCH AND TREATMENT（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要